Natural regulatory T cells in autoimmunity

References

• Mills KH. Regulatory T cells: Friend or foe in immunity to infection?. Nat Rev Immunol. 2004; 4 11: 841–855.
   PubMed Web of Science ®Google Scholar
• Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev. 2006; 212:28–50.
   PubMed Web of Science ®Google Scholar
• Faria AM, Weiner HL. Oral tolerance. Immunol Rev. 2005; 206:232–259.
   PubMed Web of Science ®Google Scholar
• Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. Conversion of peripheral CD4+ CD25 − naive T cells to CD4+ CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med. 2003; 198 12: 1875–1886.
   PubMed Web of Science ®Google Scholar
• Fehervari Z, Sakaguchi S. CD4+ Tregs and immune control. J Clin Invest. 2004; 114 9: 1209–1217.
   Google Scholar
• Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA. Natural and induced CD4+ CD25+ cells educate CD4+CD25 − cells to develop suppressive activity: The role of IL-2, TGF-β, and IL-10. J Immunol. 2004; 172 9: 5213–5221.
   PubMed Web of Science ®Google Scholar
• Zheng SG, et al., this issue.
   Google Scholar
• Chatila TA. Regulatory T cells: Key players in tolerance and autoimmunity. Endocrinol Metab Clin North Am. 2009; 38 2: 265–272.
   Google Scholar
• Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997; 389 6652: 737–742.
   PubMed Web of Science ®Google Scholar
• Bacchetta R, Bigler M, Touraine JL, Parkman R, Tovo PA, Abrams J, de Waal Malefyt R, de Vries JE, Roncarolo MG. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med. 1994; 179 2: 493–502.
   Google Scholar
• Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O'Garra A. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med. 2002; 195 5: 603–616.
   Google Scholar
• Vieira PL, Christensen JR, Minaee S, O'Neill EJ, Barrat FJ, Boonstra A, Barthlott T, Stockinger B, Wraith DC, O'Garra A. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+ CD25+ regulatory T cells. J Immunol. 2004; 172 10: 5986–5993.
   PubMed Web of Science ®Google Scholar
• McGuirk P, McCann C, Mills KH. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: A novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med. 2002; 195 2: 221–231.
   PubMed Web of Science ®Google Scholar
• Beilharz MW, Sammels LM, Paun A, Shaw K, van Eeden P, Watson MW, Ashdown ML. Timed ablation of regulatory CD4+ T cells can prevent murine AIDS progression. J Immunol. 2004; 172 8: 4917–4925.
   Google Scholar
• MacDonald AJ, Duffy M, Brady MT, McKiernan S, Hall W, Hegarty J, Curry M, Mills KH. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J Infect Dis. 2002; 185 6: 720–727.
   Google Scholar
• Doetze A, Satoguina J, Burchard G, Rau T, Löliger C, Fleischer B, Hoerauf A. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by Th3/Tr1-type cytokines IL-10 and transforming growth factor-β but not by a Th1 to Th2 shift. Int Immunol. 2000; 12 5: 623–630.
   PubMedGoogle Scholar
• Satoguina J, Mempel M, Larbi J, Badusche M, Löliger C, Adjei O, Gachelin G, Fleischer B, Hoerauf A. Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). Microbes Infect. 2002; 4 13: 1291–1300.
   Google Scholar
• Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science. 1994; 265 5176: 1237–1240.
   PubMed Web of Science ®Google Scholar
• Weiner HL. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol Rev. 2001; 182:207–214.
   PubMed Web of Science ®Google Scholar
• Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol. 2003; 3 3: 253–257.
   PubMed Web of Science ®Google Scholar
• Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol. 2001; 167 3: 1245–1253.
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol. 2003; 4 4: 330–336.
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003; 299 5609: 1057–1061.
   PubMed Web of Science ®Google Scholar
• Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001; 27:20–21.
   PubMed Web of Science ®Google Scholar
• Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001; 27:68–73.
   PubMed Web of Science ®Google Scholar
• Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, Bricarelli FD, Byrne G, McEuen M, Proll S, Appleby M, Brunkow ME. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 2001; 27:18–20.
   PubMed Web of Science ®Google Scholar
• Gavin M, Rudensky A. Control of immune homeostasis by naturally arising regulatory CD4+ T cells. Curr Opin Immunol. 2003; 15 6: 690–696.
   Google Scholar
• Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature. 2007; 445 7129: 766–770.
   PubMed Web of Science ®Google Scholar
• Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol. 2007; 8 3: 277–284.
   PubMed Web of Science ®Google Scholar
• Graca L, Le Moine A, Cobbold SP, Waldmann H. Dominant transplantation tolerance. Curr Opin Immunol. 2003; 15 5: 499–506.
   Google Scholar
• Bettini M, Vignali DA. Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol. 2009; 21 6: 612–618.
   PubMed Web of Science ®Google Scholar
• La Cava A. Natural Tregs and autoimmunity. Front Biosci. 2009; 14:333–343.
   Google Scholar
• Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity. 2009; 19 6: 899–911.
   Google Scholar
• Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, Fazekas de St Groth B, Clayberger C, Soper DM, Ziegler SF, Bluestone JA. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006; 203 7: 1701–1711.
   PubMed Web of Science ®Google Scholar
• Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, Bover L, Qin FX, Gilliet M, Liu YJ. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity. 2008; 28 6: 870–880.
   PubMed Web of Science ®Google Scholar
• Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol. 2010; 11 1: 7–13.
   PubMed Web of Science ®Google Scholar
• Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol. 2002; 3 8: 756–763.
   PubMed Web of Science ®Google Scholar
• Bensinger SJ, Bandeira A, Jordan MS, Caton AJ, Laufer TM. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4+ 25+ immunoregulatory T cells. J Exp Med. 2001; 194 4: 427–438.
   PubMed Web of Science ®Google Scholar
• Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holenbeck AE, Lerman MA, Naji A, Caton AJ. Thymic selection of CD4+ CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol. 2001; 2 4: 301–306.
   PubMed Web of Science ®Google Scholar
• Larkin JIII, Rankin AL, Picca CC, Riley MP, Jenks SA, Sant AJ, Caton AJ. CD4+ CD25+ regulatory T cell repertoire formation shaped by differential presentation of peptides from a self-antigen. J Immunol. 2008; 180 4: 2149–2157.
   PubMed Web of Science ®Google Scholar
• Olivares-Villagomez D, Wang Y, Lafaille JJ. Regulatory CD4+ T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J Exp Med. 1998; 188 10: 1883–1894.
   Google Scholar
• Zheng SG. The critical role of TGF-β1 in the development of induced Foxp3+ regulatory T cells. Int J Clin Exp Med. 2008; 1 3: 192–202.
   Google Scholar
• Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, Bluestone JA. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 2000; 12 4: 431–440.
   PubMed Web of Science ®Google Scholar
• Tai X, Cowan M, Feigenbaum L, Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol. 2005; 6 2: 152–162.
   PubMed Web of Science ®Google Scholar
• Curotto de Lafaille MA, Lino AC, Kutchukhidze N, Lafaille JJ. CD25 − T cells generate CD25+ Foxp3+ regulatory T cells by peripheral expansion. J Immunol. 2004; 173 12: 7259–7268.
   PubMedGoogle Scholar
• Curotto de Lafaille MA, Lafaille JJ. Natural and adaptive foxp3+ regulatory T cells: More of the same or a division of labor?. Immunity. 2009; 30 5: 626–635.
   PubMed Web of Science ®Google Scholar
• D'Cruz LM, Klein L. Development and function of agonist-induced CD25+ Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol. 2005; 6 11: 1152–1159.
   PubMed Web of Science ®Google Scholar
• Soper DM, Kasprowicz DJ, Ziegler SF. IL-2Rβ links IL-2R signaling with Foxp3 expression. Eur J Immunol. 2007; 37 7: 1817–1826.
   Google Scholar
• Burchill MA, Yang J, Vang KB, Farrar MA. Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol Lett. 2007; 114 1: 1–8.
   Google Scholar
• Rückert R, Brandt K, Braun A, Hoymann HG, Herz U, Budagian V, Dürkop H, Renz H, Bulfone-Paus S. Blocking IL-15 prevents the induction of allergen-specific T cells and allergic inflammation in vivo. J Immunol. 2005; 174 9: 5507–5515.
   Google Scholar
• Vang KB, Yang J, Mahmud SA, Burchill MA, Vegoe AL, Farrar MA. IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+ Foxp3+ regulatory T cell development. J Immunol. 2008; 181 5: 3285–3290.
   PubMed Web of Science ®Google Scholar
• Marie JC, Letterio JJ, Gavin M, Rudensky AY. TGF-β1 maintains suppressor function and Foxp3 expression in CD4+ CD25+ regulatory T cells. J Exp Med. 2005; 201 7: 1061–1067.
   PubMed Web of Science ®Google Scholar
• Marie JC, Liggitt D, Rudensky AY. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor. Immunity. 2006; 25 3: 441–454.
   PubMed Web of Science ®Google Scholar
• Shevach EM. CD4+ CD25+ suppressor T cells: More questions than answers. Nat Rev Immunol. 2002; 2 6: 389–400.
   PubMed Web of Science ®Google Scholar
• Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity. 2004; 21 4: 589–601.
   PubMed Web of Science ®Google Scholar
• Lim HW, Hillsamer P, Banham AH, Kim CH. Cutting edge: Direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol. 2005; 175 7: 4180–4183.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004; 22:531–562.
   PubMed Web of Science ®Google Scholar
• Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008; 8 7: 523–532.
   PubMed Web of Science ®Google Scholar
• Shevach EM. Mechanisms of Foxp3+ T regulatory cell-mediated suppression. Immunity. 2009; 30 5: 636–645.
   PubMed Web of Science ®Google Scholar
• La Cava A. Tregs are regulated by cytokines: Implications for autoimmunity. Autoimmun Rev. 2008; 8 1: 83–87.
   Google Scholar
• Shevach EM. From vanilla to 28 flavors: Multiple varieties of T regulatory cells. Immunity. 2006; 25 2: 195–201.
   PubMed Web of Science ®Google Scholar
• Thornton AM, Shevach EM. CD4+ CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998; 188 2: 287–296.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, Shimizu J, Sakaguchi S. Immunologic self-tolerance maintained by CD25+ CD4+ naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol. 1998; 10 12: 1969–1980.
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4+ CD25+T cells with regulatory properties isolated from peripheral blood. J Exp Med. 2001; 193 11: 1285–1294.
   PubMed Web of Science ®Google Scholar
• Hawrylowicz CM, O'Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol. 2005; 5 4: 271–283.
   PubMed Web of Science ®Google Scholar
• Joetham A, Takeda K, Taube C, Miyahara N, Matsubara S, Koya T, Rha YH, Dakhama A, Gelfand EW. Naturally occurring lung CD4+ CD25+ T cell regulation of airway allergic responses depends on IL-10 induction of TGF-β. J Immunol. 2007; 178 3: 1433–1442.
   PubMed Web of Science ®Google Scholar
• Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, Treuting P, Siewe L, Roers A, Henderson WRJr, Muller W, Rudensky AY. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity. 2008; 28 4: 546–558.
   PubMed Web of Science ®Google Scholar
• Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med. 1999; 190 7: 995–1004.
   PubMed Web of Science ®Google Scholar
• Bergmann C, Strauss L, Zeidler R, Lang S, Whiteside TL. Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment. Cancer Immunol Immunother. 2007; 56 9: 1429–1442.
   PubMed Web of Science ®Google Scholar
• Loser K, Apelt J, Voskort M, Mohaupt M, Balkow S, Schwarz T, Grabbe S, Beissert S. IL-10 controls ultraviolet-induced carcinogenesis in mice. J Immunol. 2007; 179 1: 365–371.
   PubMed Web of Science ®Google Scholar
• Erhardt A, Biburger M, Papadopoulos T, Tiegs G. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology. 2007; 45 2: 475–485.
   Google Scholar
• Ivars F. T cell subset-specific expression of antigen receptor β chains in α chain-transgenic mice. Eur J Immunol. 1992; 22 3: 635–639.
   Google Scholar
• Schumacher A, Wafula PO, Bertoja AZ, Sollwedel A, Thuere C, Wollenberg I, Yagita H, Volk HD, Zenclussen AC. Mechanisms of action of regulatory T cells specific for paternal antigens during pregnancy. Obstet Gynecol. 2007; 110 5: 1137–1145.
   Google Scholar
• Mann MK, Maresz K, Shriver LP, Tan Y, Dittel BN. B cell regulation of CD4+ CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol. 2007; 178 6: 3447–3456.
   PubMed Web of Science ®Google Scholar
• Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H. CD4+ CD25+ regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J Exp Med. 2002; 196 2: 237–246ShevachEM.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4+ CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor β. J Exp Med. 2001; 194 5: 629–644.
   PubMed Web of Science ®Google Scholar
• Green EA, Gorelik L, McGregor CM, Tran EH, Flavell RA. CD4+ CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-β-TGF-β receptor interactions in type 1 diabetes. Proc Natl Acad Sci USA. 2003; 100 19: 10878–10883.
   Google Scholar
• Fahlén L, Read S, Gorelik L, Hurst SD, Coffman RL, Flavell RA, Powrie F. T cells that cannot respond to TGF-β escape control by CD4+ CD25+ regulatory T cells. J Exp Med. 2005; 201 5: 737–746.
   PubMedGoogle Scholar
• McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M. CD4+ CD25+ immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 2002; 16 2: 311–323ByrneMC.
   PubMed Web of Science ®Google Scholar
• Herman AE, Freeman GJ, Mathis D, Benoist C. CD4+ CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med. 2004; 199 11: 1479–1489.
   PubMed Web of Science ®Google Scholar
• Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ. Cutting edge: Contact-mediated suppression by CD4+ CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J Immunol. 2005; 174 4: 1783–1786.
   PubMed Web of Science ®Google Scholar
• Cao X, Cai SF, Fehniger TA, Song J, Collins LI, Piwnica-Worms DR, Ley TJ. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity. 2007; 27 4: 635–646.
   PubMed Web of Science ®Google Scholar
• Zhao DM, Thornton AM, DiPaolo RJ, Shevach EM. Activated CD4+ CD25+ T cells selectively kill B lymphocytes. Blood. 2006; 107 10: 3925–3932.
   PubMed Web of Science ®Google Scholar
• Ren X, Ye F, Jiang Z, Chu Y, Xiong S, Wang Y. Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4+ CD25+ regulatory T cells. Cell Death Differ. 2007; 14 12: 2076–2084.
   Web of Science ®Google Scholar
• Garín MI, Chu CC, Golshayan D, Cernuda-Morollón E, Wait R, Lechler RI. Galectin-1: A key effector of regulation mediated by CD4+ CD25+ T cells. Blood. 2007; 109 5: 2058–2065.
   PubMed Web of Science ®Google Scholar
• de la Rosa M, Rutz S, Dorninger H, Scheffold A. Interleukin-2 is essential for CD4+ CD25+ regulatory T cell function. Eur J Immunol. 2004; 34 9: 2480–2488.
   PubMed Web of Science ®Google Scholar
• Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ. CD4+ CD25+ Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol. 2007; 8 12: 1353–1362.
   PubMed Web of Science ®Google Scholar
• Oberle N, Eberhardt N, Falk CS, Krammer PH. Rapid suppression of cytokine transcription in human CD4+ CD25 T cells by CD4+ Foxp3+ regulatory T cells: Independence of IL-2 consumption, TGF-β, and various inhibitors of TCR signaling. J Immunol. 2007; 179 6: 3578–3587Suri-PayerE.
   Web of Science ®Google Scholar
• Tran DQ, Andersson J, Hardwick D, Bebris L, Illei GG, Shevach EM. Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures. Blood. 2009; 113 21: 5125–5133.
   PubMedGoogle Scholar
• Bopp T, Becker C, Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Heib V, Becker M, Kubach J, Schmitt S, Stoll S, Schild H, Staege MS, Stassen M, Jonuleit H. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med. 2007; 204 6: 1303–1310SchmittE.
   PubMed Web of Science ®Google Scholar
• Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med. 2007; 204 6: 1257–1265.
   PubMed Web of Science ®Google Scholar
• Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, Höpner S, Centonze D, Bernardi G, Dell'Acqua ML, Rossini PM, Battistini L, Rötzschke O, Falk K. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: Hydrolysis of extracellular ATP and immune suppression. Blood. 2007; 110 4: 1225–1232.
   PubMed Web of Science ®Google Scholar
• Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, Mosmann TR. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J Immunol. 2006; 177 10: 6780–6786.
   PubMed Web of Science ®Google Scholar
• Oukka M. Interplay between pathogenic Th17 and regulatory T cells. Ann Rheum Dis. 2007; 66 Suppl 3: iii87–iii90.
   PubMedGoogle Scholar
• Zarek PE, Huang CT, Lutz ER, Kowalski J, Horton MR, Linden J, Drake CG, Powell JD. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood. 2008; 111 1: 251–259.
   PubMed Web of Science ®Google Scholar
• Misra N, Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV. Cutting edge: Human CD4+ CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol. 2004; 172 8: 4676–4680.
   Web of Science ®Google Scholar
• Serra P, Amrani A, Yamanouchi J, Han B, Thiessen S, Utsugi T, Verdaguer J, Santamaria P. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+ CD25+ T cells. Immunity. 2003; 19 6: 877–889.
   Web of Science ®Google Scholar
• Thornton AM, Piccirillo CA, Shevach EM. Activation requirements for the induction of CD4+ CD25+ T cell suppressor function. Eur J Immunol. 2004; 34 2: 366–376.
   Google Scholar
• Read S, Greenwald R, Izcue A, Robinson N, Mandelbrot D, Francisco L, Sharpe AH, Powrie F. Blockade of CTLA-4 on CD4+ CD25+ regulatory T cells abrogates their function in vivo. J Immunol. 2006; 177 7: 4376–4383.
   PubMed Web of Science ®Google Scholar
• Liang B, Workman C, Lee J, Chew C, Dale BM, Colonna L, Flores M, Li N, Schweighoffer E, Greenberg S, Tybulewicz V, Vignali D, Clynes R. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J Immunol. 2008; 180 9: 5916–5926.
   PubMed Web of Science ®Google Scholar
• Kuhn A, Beissert S, Krammer PH. CD4+ CD25+ regulatory T cells in human lupus erythematosus. Arch Dermatol Res. 2009; 301 1: 71–81.
   Google Scholar
• La Cava A. T-regulatory cells in systemic lupus erythematosus. Lupus. 2008; 17 5: 421–425.
   Google Scholar
• Mellor-Pita S, Citores MJ, Castejon R, Tutor-Ureta P, Yebra-Bango M, Andreu JL, Vargas JA. Decrease of regulatory T cells in patients with systemic lupus erythematosus. Ann Rheum Dis. 2006; 65 4: 553–554.
   Google Scholar
• Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, Nochy D, Debré P, Piette JC, Gorochov G. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol. 2005; 175 12: 8392–8400.
   PubMed Web of Science ®Google Scholar
• Lee JH, Wang LC, Lin YT, Yang YH, Lin DT, Chiang BL. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology. 2006; 117 2: 280–286.
   Google Scholar
• Lyssuk EY, Torgashina AV, Soloviev SK, Nassonov EL, Bykovskaia SN. Reduced number and function of CD4+ CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol. 2007; 601:113–119.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhang X, Tang F, Zhu L, Liu Y. Reduction of forkhead box P3 levels in CD4+ CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin Exp Immunol. 2008; 153 2: 182–187.
   Google Scholar
• Cepika AM, Marinic I, Morovic-Vergles J, Soldo-Juresa D, Gagro A. Effect of steroids on the frequency of regulatory T cells and expression of FOXP3 in a patient with systemic lupus erythematosus: A two-year follow-up. Lupus. 2007; 16 5: 374–377.
   Google Scholar
• Sfikakis PP, Souliotis VL, Fragiadaki KG, Moutsopoulos HM, Boletis JN, Theofilopoulos AN. Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clin Immunol. 2007; 123 1: 66–73.
   PubMed Web of Science ®Google Scholar
• Bonelli M, Savitskaya A, Von Dalwigk K, Steiner CW, Aletaha D, Smolen JS, Scheinecker C. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int Immunol. 2008; 20 7: 861–868.
   Google Scholar
• Valencia X, Yarboro C, Illei G, Lipsky PE. Deficient CD4+ CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol. 2007; 178 4: 2579–2588.
   PubMed Web of Science ®Google Scholar
• Yan B, Ye S, Chen G, Kuang M, Shen N, Chen S. Dysfunctional CD4+, CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-α-producing antigen-presenting cells. Arthritis Rheum. 2008; 58 3: 801–812.
   Google Scholar
• Vargas-Rojas MI, Crispín JC, Richaud-Patin Y, Alcocer-Varela J. Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus. 2008; 17 4: 289–294.
   Google Scholar
• Wolf D, Hochegger K, Wolf AM, Rumpold HF, Gastl G, Tilg H, Mayer G, Gunsilius E, Rosenkranz AR. CD4+ CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol. 2005; 16 5: 1360–1370.
   Google Scholar
• Scalapino KJ, Tang Q, Bluestone JA, Bonyhadi ML, Daikh DI. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol. 2006; 177 3: 1451–1459.
   PubMed Web of Science ®Google Scholar
• Morgan ME, Flierman R, van Duivenvoorde LM, Witteveen HJ, van Ewijk W, van Laar JM, de Vries RR, Toes RE. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 2005; 52 7: 2212–2221.
   PubMedGoogle Scholar
• Morgan ME, Sutmuller RP, Witteveen HJ, van Duivenvoorde LM, Zanelli E, Melief CJ, Snijders A, Offringa R, de Vries RR, Toes RE. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum. 2003; 48 5: 1452–1460.
   PubMedGoogle Scholar
• Lawson CA, Brown AK, Bejarano V, Douglas SH, Burgoyne CH, Greenstein AS, Boylston AW, Emery P, Ponchel F, Isaacs JD. Early rheumatoid arthritis is associated with a deficit in the CD4+ CD25high regulatory T cell population in peripheral blood. Rheumatology (Oxford). 2006; 45 10: 1210–1217.
   Google Scholar
• Cao D, Malmström V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol. 2003; 33 1: 215–223.
   PubMed Web of Science ®Google Scholar
• de Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, de Jager W, Pugayung G, Giannoni F, Rijkers G, Albani S, Kuis W, Prakken B. CD4+ CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol. 2004; 172 10: 6435–6443.
   PubMed Web of Science ®Google Scholar
• Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med. 2004; 199 7: 971–979.
   PubMed Web of Science ®Google Scholar
• Matarese G, Carrieri PB, La Cava A, Perna F, Sanna V, De Rosa V, Aufiero D, Fontana S, Zappacosta S. Leptin increase in multiple sclerosis associates with reduced number of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci USA. 2005; 102 14: 5150–5155.
   PubMed Web of Science ®Google Scholar
• Kohm AP, Carpentier PA, Anger HA, Miller SD. Cutting edge: CD4+ CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol. 2002; 169 9: 4712–4716.
   PubMed Web of Science ®Google Scholar
• Paust S, Cantor H. Regulatory T cells and autoimmune disease. Immunol Rev. 2005; 204:195–207.
   PubMed Web of Science ®Google Scholar
• Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI. Defective suppressor function in CD4+ CD25+ T-cells from patients with type 1 diabetes. Diabetes. 2005; 54 1: 92–99.
   PubMed Web of Science ®Google Scholar
• Battaglia M, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T, Roncarolo MG. Rapamycin promotes expansion of functional CD4+ CD25+ FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol. 2006; 177 12: 8338–8347.
   PubMed Web of Science ®Google Scholar
• Pop SM, Wong CP, Culton DA, Clarke SH, Tisch R. Single cell analysis shows decreasing FoxP3 and TGFβ1 coexpressing CD4+ CD25+ regulatory T cells during autoimmune diabetes. J Exp Med. 2005; 201 8: 1333–1346.
   PubMed Web of Science ®Google Scholar
• Gregori S, Giarratana N, Smiroldo S, Adorini L. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol. 2003; 171 8: 4040–4047.
   Google Scholar
• Pop SM, Wong CP, He Q, Wang Y, Wallet MA, Goudy KS, Tisch R. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice. Diabetes. 2007; 56 5: 1395–1402.
   PubMed Web of Science ®Google Scholar
• Tritt M, Sgouroudis E, d'Hennezel E, Albanese A, Piccirillo CA. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes. 2008; 57 1: 113–123.
   Google Scholar
• Poussier P, Ning T, Murphy T, Dabrowski D, Ramanathan S. Impaired post-thymic development of regulatory CD4+ 25+ T cells contributes to diabetes pathogenesis in BB rats. J Immunol. 2005; 174 7: 4081–4089.
   Google Scholar
• Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med. 2004; 199 11: 1467–1477.
   PubMed Web of Science ®Google Scholar
• Bluestone JA, Tang Q. Therapeutic vaccination using CD4+ CD25+ antigen-specific regulatory T cells. Proc Natl Acad Sci USA. 2004; 101 Suppl 2: 14622–14626.
   PubMedGoogle Scholar
• Feuerer M, Shen Y, Littman DR, Benoist C, Mathis D. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity. 2009; 31 4: 654–664.
   PubMed Web of Science ®Google Scholar
• Maul J, Loddenkemper C, Mundt P, Berg E, Giese T, Stallmach A, Zeitz M, Duchmann R. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology. 2005; 128 7: 1868–1878.
   Google Scholar
• Makita S, Kanai T, Nemoto Y, Totsuka T, Okamoto R, Tsuchiya K, Yamamoto M, Kiyono H, Watanabe M. Intestinal lamina propria retaining CD4+ CD25+ regulatory T cells is a suppressive site of intestinal inflammation. J Immunol. 2007; 178 8: 4937–4946.
   Google Scholar
• Powrie F, Mason D. OX-22high CD4+T cells induce wasting disease with multiple organ pathology: Prevention by the OX-22low subset. J Exp Med. 1990; 172 6: 1701–1708.
   PubMed Web of Science ®Google Scholar
• Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL. A critical role for transforming growth factor-β but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med. 1996; 183 6: 2669–2674.
   PubMed Web of Science ®Google Scholar
• Vasu C, Dogan RN, Holterman MJ, Prabhakar BS. Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis. J Immunol. 2003; 170 11: 5511–5522.
   Google Scholar